MedTrace Logo

Quality of Life Improvements With Cord Blood Plasma

NCT03229785 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-01-24

No results posted yet for this study

Summary

This study aims to look at whether human umbilical cord blood plasma (HUCBP) is safe for intravascular (iv) administration; and whether it provides any reversal of frailty or other age-related biological measures.

Conditions

  • Aging

Interventions

BIOLOGICAL

Human Umbilical Cord Blood Plasma

Plasma collected from human umbilical cord blood

Sponsors & Collaborators

  • Hexagon Therapies, LLC

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-01-31
Completion
2019-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03229785 on ClinicalTrials.gov